11 – 20 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Rationale and design of switch Swedeheart : A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
On the Natural History of Coronary Artery Disease : A Longitudinal Nationwide Serial Angiography Study
(
- Contribution to journal › Article
-
Mark
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention : A nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease
(
- Contribution to journal › Article
-
Mark
5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve
(
- Contribution to journal › Article
- 2021
-
Mark
Expression of Paracrine Effectors in Human Adipose-Derived Mesenchymal Stem Cells Treated With Plasma From Brown Bears (Ursus arctos)
(
- Contribution to journal › Article
-
Mark
Clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent p2y12 inhibitors -A validate-swedeheart substudy
(
- Contribution to journal › Article
-
Mark
Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent : a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
Instantaneous wave-free ratio compared with fractional flow reserve in PCI : A cost-minimization analysis
(
- Contribution to journal › Article
-
Mark
Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI) : study protocol for a randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Article